Jazz star Tommy Smith sacked from Conservatoire role - BBC
2 hours ago • Google News
Jazz Pharmaceuticals PLC (JAZZ)
US$ 144.16993.22%
Price Chart
Key Statistics
Market Cap
$ 6.57B
P/E Ratio
14.74
Revenue (TTM)
$ 4.06B
Volume
2.62M
52W High
$ 148.06
52W Low
$ 95.49
Dividend Yield
0.00%
Beta
0.33
Technicals
50-Day MA
108.1698
200-Day MA
118.3586
52 Week High
148.0568
52 Week Low
95.49
About JAZZ
Jazz Pharmaceuticals plc identifies, develops, and commercializes pharmaceutical products in the United States, Europe, and internationally. The company offers Xywav to treat cataplexy or excessive da.
Employees
2800
Headquarters
Dublin, Ireland
CEO
Mr. Bruce C. Cozadd
Latest News
Rochester Jazz Festival picks: Shows to see each day - Democrat and Chronicle
1 hour ago • Google News
Environment, Social and Governance (ESG) Risk Ratings
Total ESG Risk Score
31.66
Percentile: 51.04
Environmental Risk Score
4.18
Percentile: 8
Social Risk Score
24.74
Percentile: 8
Governance Risk Score
13.74
Percentile: 8
Controversy Level
ESG data provided by Sustainalytics, Inc.
JAZZ
Category Average
1Low Controversy Level
NoneSevere
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg